What analysts think CSTL stock price will be. NASDAQ RKDA opened at 054 on Tuesday.
Analysts Just Shipped A Captivating Upgrade To Their Castle Biosciences Inc Nasdaq Cstl Estimates
Castle Biosciences Inc CSTL Exchange.
. Zacks Expert Aims for His Next Explosive 4771 Biotech Boom. Learn how to buy Castle Biosciences Inc CSTL stocks easily by following a step-by-step guide and compare the best stocks trading platforms. The Company is focused on providing physicians and.
Industry stock comparison between Castle Biosciences and Ritchie Bros Auctioneers. Arcadia Biosciences Stock Up 32. Castle Biosciences Inc.
Do Your Investments Align with Your Goals. What is CSTLs Earnings Per Share EPS forecast. The 7 analysts offering 12-month price forecasts for Castle Biosciences Inc have a median target of 4800 with a high estimate of 6500 and a low estimate of 4000.
Is currently rated as a Zacks Rank 3 and we are expecting an inline return. Castle Biosciences Inc. Wide Range Of Investment Choices Including Options Futures and Forex.
The average Castle Biosciences stock price prediction forecasts a potential upside of 8241 from the current CSTL share price of 2933. Type sellbuy option MAETZOLD. Is a commercial-stage diagnostics company.
Arcadia Biosciences has a 12 month low of 051 and a 12 month high of 266. What type of owners hold Castle Biosciences Inc stock. Is Castle Biosciences Inc NASDAQCSTL stock a buy or a sell.
Find a Dedicated Financial Advisor Now. Toggle menu toggle menu. Castle Biosciences Insider Transactions Over The Last Year In the last twelve months the biggest single sale by an insider was when the Chief Business Officer Bernhard.
Get the latest Castle Biosciences Inc CSTL detailed stock quotes stock data Real-Time ECN charts stats and more. Check out the forecast and prediction here. Ad An Edward Jones Financial Advisor Can Partner Through Lifes MomentsGet Started Today.
From Novice To Expert Compare Brokers To Trade Stocks. See the latest Castle Biosciences Inc stock price NASDAQCSTL related news valuation dividends and more to help you make your investing decisions. Maetzold sold 2188 shares of the stock in a transaction on Monday September 26th.
Zacks proprietary data indicates that Castle Biosciences Inc. In a report issued on July 25 Mark Massaro from BTIG reiterated a Buy rating on Castle Biosciences CSTL Research Report with a price target of 4500. CSTL stock returns are also predicted based on historical data.
The business has a. Get the latest Castle Biosciences stock price and detailed information including CSTL news historical charts and realtime prices. Name Hold Shares Value Type.
Our Top Picks For Stock Brokers. The company has a market capitalization of 1209 million a price-to-earnings ratio of -061. NASDAQCSTL - Get Rating insider Derek J.
Ad See Brokerages That Offer Mobile Trading Zero Commissions Multiple Accounts More. Shares of Arcadia Biosciences stock opened at 054 on Tuesday. Just-Updated Report Taps Small-Cap Biotechs with Gigantic Potential.
Castle Biosciences Inc stock is up 9398 over the last 12 months and the average rating from Wall Street analysts is a Strong BuyInvestorsObservers proprietary.
Castle Biosciences Ipo The Buying Opportunity Starts At 3x 3 5x Sales Nasdaq Cstl Seeking Alpha
Analysts Just Published A Bright New Outlook For Castle Biosciences Inc S Nasdaq Cstl Simply Wall St News
Castle Biosciences Ipo The Buying Opportunity Starts At 3x 3 5x Sales Nasdaq Cstl Seeking Alpha
Castle Biosciences Inc Cstl Stock Price Quote News Stock Analysis
Cstl Stock Forecast Price News Castle Biosciences
Castle Biosciences Inc Cstl Stock Price Quote News Stock Analysis
Castle Biosciences Inc Cstl Stock Price News Info The Motley Fool
Arkg Holdings Of Castle Biosciences Cstl Updated Daily
Castle Biosciences Stock Nasdaq Cstl Quotes And News Summary Benzinga
Castle Biosciences Inc Cstl Stock Price Us14843c1053 Marketscreener
Cstl Stock Price And Chart Nasdaq Cstl Tradingview
Is Cstl A Good Stock To Buy Now
Post Ipo Review Castle Biosciences Grows Despite Pandemic S Effects Ipos On Thestreet U S Ipo Research Opinion
Post Ipo Review Castle Biosciences Grows Despite Pandemic S Effects Ipos On Thestreet U S Ipo Research Opinion
Castle Biosciences Cstl Investor Presentation Slideshow Nasdaq Cstl Seeking Alpha
Reasons Behind The 40 Jump In Castle Biosciences Stock Since Early November
Castle Biosciences Inc Cstl Stock 52 Week High Low
Analysts Start Castle Biosciences At Buy And Op With Pts Of 25 To 28 Biotuesdays
What S Next For Castle Biosciences Stock
